Determination of silodosin in human plasma by liquid chromatography-tandem mass spectrometry

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 877, Issue 29, 2009, Pages 3724-3728

  Zhao, Xia ^a   Liu, Yuwang ^a   Xu, Junyu ^a   Zhang, Dan ^b,c   Zhou, Ying ^a   Gu, Jingkai ^b   Cui, Yimin ^a  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

^b JILIN UNIVERSITY   (China)

^c PEKING UNIVERSITY   (China)

Author keywords

1A Adrenergic receptor antagonist; LC MS MS; Silodosin

Indexed keywords

ADRENERGIC RECEPTORS; AGILENT; AMMONIUM ACETATE; HUMAN PLASMAS; INTERNAL STANDARDS; LC-MS/MS; LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY; LIQUID-LIQUID EXTRACTION; LOWER LIMIT OF QUANTIFICATIONS; METHYL-T-BUTYL ETHERS; MOBILE PHASE; MULTIPLE REACTION MONITORING; PHARMACOKINETIC STUDIES; PLASMA SAMPLES; STANDARD CURVES; TANDEM MASS SPECTROMETRIC; TURBOIONSPRAY;

ACETONITRILE; AMMONIUM COMPOUNDS; CHROMATOGRAPHIC ANALYSIS; CHROMATOGRAPHY; ETHERS; HIGH PRESSURE LIQUID CHROMATOGRAPHY; IONIZATION OF LIQUIDS; LIQUIDS; MASS SPECTROMETERS; MASS SPECTROMETRY; PLASMA (HUMAN); PLASMAS; POSITIVE IONS;

SOLVENT EXTRACTION;

ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 1A ADRENERGIC RECEPTOR; SILODOSIN;

ANALYTIC METHOD; ARTICLE; BLOOD SAMPLING; CALIBRATION; DRUG BLOOD LEVEL; DRUG CAPSULE; DRUG DETERMINATION; DRUG STABILITY; DRUG STRUCTURE; HUMAN; HUMAN EXPERIMENT; LIQUID CHROMATOGRAPHY; NORMAL HUMAN; PLASMA; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; SINGLE DRUG DOSE; TANDEM MASS SPECTROMETRY; VALIDATION STUDY;

CHROMATOGRAPHY, LIQUID; HUMANS; INDOLES; RECEPTORS, ADRENERGIC, ALPHA-1; REPRODUCIBILITY OF RESULTS; TANDEM MASS SPECTROMETRY;

EID: 72049121847     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2009.08.025     Document Type: Article

References (11)

1. Oesterling J.E. N. Engl. J. Med. 332 (1995) 99
2. Bylund D.B., Eikenberg D.C., Hieble J.P., Langer S.Z., Lefkowitz R.J., Minneman K.P., Molinoff P.B., Ruffolo Jr. R.R., and Trendelenburg U. J. Pharmacol. Rev. 46 (1994) 121
3. Hieble J.P., Bylund D.B., Clarke D.E., Eikenburg D.C., Langer S.Z., Lefkowitz R.J., Minneman K.P., and Ruffolo Jr. R.R. J. Pharmacol. Rev. 47 (1995) 267
4. Chapple C.R., Burt R.P., Andersson P.O., Greengrass P., Wyllie M., and Marshall I. Br. J. Urol. 74 (1994) 585
5. Muramatsu I., Oshita M., Ohmura T., Kigoshi S., Akino H., Gobara M., and Okada K. Br. J. Urol. 74 (1994) 572
6. Chapple C., and Andersson K.E. World J. Urol. 19 (2002) 397
7. Ishiguro M., Futabayashi Y., Ohnuki T., Ahmed M., Muramatsu I., and Nagatomo T. J. Life Sci. 71 (2002) 2531
8. Murata S., Taniguchi T., Takahashi M., Okada K., Akiyama K., and Muramatsu I. J. Urol. 164 (2000) 578
9. Kawabe K., Yoshida M., Homma Y., and Silodosin Clinical Study Group. Br. J. Urol. Int. 98 (2006) 1019
10. Matsubara Y., kanazawa T., Kojima Y., Abe Y., Kobayashi K., Kanbe H., Harada H., Momose Y., Terakado S., Adachi Y., and Midgley I. Yakugaku Zasshi 126 (2006) 237
11. Shimizu T., Miyashita I., Matsubara Y., Ikeda M., and Yamaguchi M. Yakugaku Zasshi 126 (2006) 257